Finance

Lists
300181:SHE
Zhejiang Jolly Pharmaceutical Co Ltd
CN¥13.12
+1.16%
(+0.15) 1D
Oct 16, 3:04:31 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300181...
Open
CN¥13.01
High
CN¥13.21
Low
CN¥12.98
Mkt. cap
9.20B
Avg. vol.
8.80M
Volume
8.32M
Dividend
4.00%
Quarterly dividend
CN¥0.13
Ex-dividend date
Sep 23, 2026
P/E ratio
14.05
52-wk high
CN¥19.42
52-wk low
CN¥12.30
EPS
CN¥0.93
Shares outstanding
701.39M
No. of employees
3K
Open
CN¥13.01
High
CN¥13.21
Low
CN¥12.98
Mkt. cap
9.20B
Avg. vol.
8.80M
Volume
8.32M
Dividend
4.00%
Quarterly dividend
CN¥0.13
Ex-dividend date
Sep 23, 2026
P/E ratio
14.05
52-wk high
CN¥19.42
52-wk low
CN¥12.30
EPS
CN¥0.93
Shares outstanding
701.39M
No. of employees
3K
News stories
From web sources and news partners
About Zhejiang Jolly Pharmaceutical Co Ltd
CEO-
Employees2.86K
Founded1995
Headquarters-
SectorPharmaceutical industry
Websitezuoli.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
680.26M
761.05M
897.80M
866.34M
Cost of goods sold
270.73M
312.62M
324.69M
339.56M
Cost of revenue
270.73M
312.62M
324.69M
339.56M
Research and development expenses
16.58M
27.59M
10.62M
12.03M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
236.27M
306.06M
329.11M
314.16M
Operating expense
231.44M
327.68M
328.51M
318.51M
Total operating expenses
502.17M
640.30M
653.20M
658.07M
Operating income
178.09M
120.75M
244.60M
208.28M
Other non operating income
-6.86M
6.88M
-37.17K
-28.28K
EBT including unusual items
162.87M
144.91M
237.61M
209.06M
EBT excluding unusual items
168.22M
124.44M
241.07M
204.33M
Income tax expense
23.95M
20.58M
35.60M
31.81M
Effective tax rate
14.70%
14.20%
14.98%
15.22%
Other operating expenses
-24.00M
-2.37M
-17.70M
-7.60M
Net income
136.47M
121.96M
199.59M
175.34M
Net profit margin
20.06%
16.03%
22.23%
20.24%
Earnings per share
-
-
-
-
Interest and investment income
947.01K
633.16K
640.44K
560.35K
Interest expense
-3.96M
-3.82M
-4.13M
-4.48M
Net interest expenses
-3.01M
-3.19M
-3.49M
-3.92M
Depreciation and amortization charges
-
-
-
-
EBITDA
194.89M
139.48M
263.33M
234.34M
Gain or loss from assets sale
-23.17K
-591.24K
-
195.05K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps